Medtronic Furthers Move toward Holistic Diabetes Management by Integrating Devices, Data and Consumer Technology DUBLIN - September 28, 2015 - Medtronic plc (MDT), the global leader in medical ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE:MDT) today announced the start of its CONNECT SM trial, which will further substantiate the impact of Medtronic’s most advanced devices with Conexus™ ...

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns DUBLIN - October 24, 2016 - Medtronic plc (MDT), the ...

I recently had the chance to try out the latest in diabetes tech from Medtronic, conducting a 14-day test drive of the new Minimed Connect data display platform. This new system shows both insulin ...

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

The technology was approved by FDA in June and unveiled at the Scientific Sessions of the American Diabetes Association. Medtronic today announced that its MiniMed Connect technology, which displays ...

Medtronic launches MiniMed 780G with Abbott sensor integration, expanding its diabetes ecosystem ahead of a planned spinoff.

Medtronic plc. MDT recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation to the ...

Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott (ABT)'s FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery ...